Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Fortress Biotech (FBIO) over the last 11 years, with Q3 2025 value amounting to $28.7 million.

  • Fortress Biotech's Goodwill & Intangibles rose 6067.03% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 6067.03%. This contributed to the annual value of $31.9 million for FY2024, which is 5706.12% up from last year.
  • As of Q3 2025, Fortress Biotech's Goodwill & Intangibles stood at $28.7 million, which was up 6067.03% from $29.7 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Goodwill & Intangibles registered a high of $31.9 million during Q4 2024, and its lowest value of $12.6 million during Q4 2021.
  • For the 5-year period, Fortress Biotech's Goodwill & Intangibles averaged around $23.8 million, with its median value being $21.9 million (2023).
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Goodwill & Intangibles was 18503.07% (2021), while the steepest drop was 3253.79% (2021).
  • Over the past 5 years, Fortress Biotech's Goodwill & Intangibles (Quarter) stood at $12.6 million in 2021, then soared by 116.67% to $27.2 million in 2022, then dropped by 25.41% to $20.3 million in 2023, then skyrocketed by 57.06% to $31.9 million in 2024, then decreased by 10.02% to $28.7 million in 2025.
  • Its last three reported values are $28.7 million in Q3 2025, $29.7 million for Q2 2025, and $30.8 million during Q1 2025.